Abstract

e18514Background: The pivotal trial (PACE) studied the use of PON in adult pts with refractory Ph+ ALL and formed the basis of approval of PON. Prescribing data tracked by the specialty pharmacy ex...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call